UB Paderborn / Katalog / Suche / in CDI

26 – 50 von 1.338

Sortiert nach

Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein

The Journal of immunology (1950), 1995-09, Vol.155 (6), p.3013

1995

Volltextzugriff (PDF)

DNA Based Therapy with Diphtheria Toxin-A BC-819: A Phase 2b Marker Lesion Trial in Patients with Intermediate Risk Nonmuscle Invasive Bladder Cancer

The Journal of urology, 2014-06, Vol.191 (6), p.1697-1702

2014

Volltextzugriff (PDF)

Incidence and Treatment of Complications of Bacillus Calmette-Guerin Intravesical Therapy in Superficial Bladder Cancer

The Journal of urology, 1992-03, Vol.147 (3), p.596-600

1992

Volltextzugriff (PDF)

Use of a New Tumor Marker, Urinary NMP22, in the Detection of Occult or Rapidly Recurring Transitional Cell Carcinoma of the Urinary Tract Following Surgical Treatment

The Journal of urology, 1996-08, Vol.156 (2), p.363-367

1996

Volltextzugriff (PDF)

Focal liver lesions: pattern-based classification scheme for enhancement at arterial phase CT

Radiology, 2000-06, Vol.215 (3), p.746

2000

Volltextzugriff (PDF)

Cancer risk after renal transplantation in the nordic countries, 1964–1986

International journal of cancer, 1995-01, Vol.60 (2), p.183-189

1995

Volltextzugriff (PDF)

Bacillus Calmette-Guérin With or Without Interferon α-2b and Megadose Versus Recommended Daily Allowance Vitamins During Induction and Maintenance Intravesical Treatment of Nonmuscle Invasive Bladder Cancer

The Journal of urology, 2010-11, Vol.184 (5), p.1915-1919

2010

Volltextzugriff (PDF)

Preventing Progression and Improving Survival with BCG Maintenance

European urology, 2000-01, Vol.37 (1), p.9-15

Lamm, D.L.

2000

Volltextzugriff (PDF)

Contemporary oncologic outcomes of second induction course BCG in patients with nonmuscle invasive bladder cancer

Urologic oncology, 2020-01, Vol.38 (1), p.5.e9-5.e16

2020

Volltextzugriff (PDF)

Intravesical sequential gemcitabine and docetaxel versus bacillus calmette-guerin (BCG) plus interferon in patients with recurrent non-muscle invasive bladder cancer following a single induction course of BCG

Urologic oncology, 2022-01, Vol.40 (1), p.9.e1-9.e7

2022

Volltextzugriff (PDF)

COMPLICATIONS OF LAPAROSCOPIC NEPHRECTOMY: THE MAYO CLINIC EXPERIENCE

The Journal of urology, 2004-04, Vol.171 (4), p.1447-1450

2004

Volltextzugriff (PDF)

Antitumor activity of common antibiotics against superficial bladder cancer

Urology (Ridgewood, N.J.), 2004-03, Vol.63 (3), p.457-460

2004

Volltextzugriff (PDF)

Intravesical therapy for superficial bladder cancer: slow but steady progress

Journal of clinical oncology, 2003-12, Vol.21 (23), p.4259-4260

Lamm, Donald L

2003

Volltextzugriff (PDF)

Pelvic recurrence after radical cystectomy: a call to arms

BJU international, 2015-08, Vol.116 (2), p.172-173

2015

Volltextzugriff (PDF)

Erratum to: Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma

Journal for immunotherapy of cancer, 2017-09, Vol.5 (1), p.80-80, Article 80

2017

Volltextzugriff (PDF)

A new frequent allele is the missing link in the structural polymorphism of the human mannan-binding protein

Immunogenetics (New York), 1994-01, Vol.40 (1), p.37-44

1994

Volltextzugriff (PDF)

The neutron long counter NERO for studies of β -delayed neutron emission in the r-process

Nuclear instruments & methods in physics research. Section A, Accelerators, spectrometers, detectors and associated equipment, 2010-06, Vol.618 (1), p.275-283

2010

Volltextzugriff (PDF)

Apparent Failure of Current Intravesical Chemotherapy Prophylaxis to Influence the Long-Term Course of Superficial Transitional Cell Carcinoma of the Bladder

The Journal of urology, 1995-05, Vol.153 (5), p.1444-1450

1995

Volltextzugriff (PDF)

Re: Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guérin, and Bacillus Calmette-Guérin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder

European urology, 2011-06, Vol.59 (6), p.1065-1065

Lamm, Donald L

2011

Volltextzugriff (PDF)

Superficial bladder cancer therapy

TheScientificWorld, 2004, Vol.4 Suppl 1, p.387-399

2004

Volltextzugriff (PDF)

A Randomized Trial of Intravesical Doxorubicin and Immunotherapy with Bacille Calmette–Guérin for Transitional-Cell Carcinoma of the Bladder

The New England journal of medicine, 1991-10, Vol.325 (17), p.1205-1209

1991

Volltextzugriff (PDF)

Quinolone antibiotics: a potential adjunct to intravesical chemotherapy for bladder cancer

Urology (Ridgewood, N.J.), 1999-07, Vol.54 (1), p.56-61

1999

Volltextzugriff (PDF)

26 – 50 von 1.338

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.080)
Mit Volltextzugriff
(901)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

5 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(645)
Life Sciences & Biomedicine
(492)
Humans
(457)
Male
(263)
Biological And Medical Sciences
(235)
Female
(232)
Medical Sciences
(184)
Physical Sciences
(142)
Animals
(139)
Adult
(117)
Urology & Nephrology
(114)
Physics
(109)
Middle Aged
(103)
Aged
(97)
Technology
(89)
Immunology
(85)
Urinary Bladder Neoplasms - Therapy
(85)
Bcg Vaccine - Therapeutic Use
(68)
Engineering
(62)
Exact Sciences And Technology
(62)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

The Journal Of Urology
(146)
Ieee Transactions On Applied Superconductivity
(92)
Tissue Antigens
(49)
Physical Review Letters
(37)
Physical Review. C, Nuclear Physics
(33)
Urology
(30)
Journal Of Applied Physiology
(25)
Endocrinology
(19)
European Urology
(17)
Neurochemical Research
(14)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein

DNA Based Therapy with Diphtheria Toxin-A BC-819: A Phase 2b Marker Lesion Trial in Patients with Intermediate Risk Nonmuscle Invasive Bladder Cancer

Incidence and Treatment of Complications of Bacillus Calmette-Guerin Intravesical Therapy in Superficial Bladder Cancer

Use of a New Tumor Marker, Urinary NMP22, in the Detection of Occult or Rapidly Recurring Transitional Cell Carcinoma of the Urinary Tract Following Surgical Treatment

Focal liver lesions: pattern-based classification scheme for enhancement at arterial phase CT

Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial

Publisher Correction: Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial

Author Correction: Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial

Cancer risk after renal transplantation in the nordic countries, 1964–1986

Bacillus Calmette-Guérin With or Without Interferon α-2b and Megadose Versus Recommended Daily Allowance Vitamins During Induction and Maintenance Intravesical Treatment of Nonmuscle Invasive Bladder Cancer

Preventing Progression and Improving Survival with BCG Maintenance

Contemporary oncologic outcomes of second induction course BCG in patients with nonmuscle invasive bladder cancer

Intravesical sequential gemcitabine and docetaxel versus bacillus calmette-guerin (BCG) plus interferon in patients with recurrent non-muscle invasive bladder cancer following a single induction course of BCG

COMPLICATIONS OF LAPAROSCOPIC NEPHRECTOMY: THE MAYO CLINIC EXPERIENCE

Antitumor activity of common antibiotics against superficial bladder cancer

Intravesical therapy for superficial bladder cancer: slow but steady progress

Pelvic recurrence after radical cystectomy: a call to arms

Erratum to: Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma

A new frequent allele is the missing link in the structural polymorphism of the human mannan-binding protein

The neutron long counter NERO for studies of β -delayed neutron emission in the r-process

Apparent Failure of Current Intravesical Chemotherapy Prophylaxis to Influence the Long-Term Course of Superficial Transitional Cell Carcinoma of the Bladder

Superficial bladder cancer therapy

A Randomized Trial of Intravesical Doxorubicin and Immunotherapy with Bacille Calmette–Guérin for Transitional-Cell Carcinoma of the Bladder

Quinolone antibiotics: a potential adjunct to intravesical chemotherapy for bladder cancer

Suchergebnisse filtern